Health Economics Review

2011 - 2025

Current editor(s): J. Matthias Graf von der Schulenburg

From Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().

Access Statistics for this journal.
Is something missing from the series or not right? See the RePEc data check for the archive and series.

Volume 3, issue 1, 2013

Health-related quality of life questionnaires in lung cancer trials: a systematic literature review pp. 1-10

Kathrin Damm, Nicole Roeske and Christian Jacob

Meta-analysis of alcohol price and income elasticities – with corrections for publication bias pp. 1-10

Jon Nelson

Review of economic evidence in the prevention and early detection of colorectal cancer pp. 1-10

Kim Jeong and John Cairns

Cost-effectiveness analysis of azacitidine in the treatment of high-risk myelodysplastic syndromes in Spain pp. 1-10

Carlos Crespo, Estela Moreno, Jordi Sierra, Suzan Serip and Marta Rubio

Do health economic evaluations using observational data provide reliable assessment of treatment effects? pp. 1-7

Dimitrios Rovithis

Does overcrowding and health insurance type impact patient outcomes in emergency departments? pp. 1-7

Pedro de Araujo, Maroula Khraiche and Andrea Tukan

Severity index for rheumatoid arthritis and its association with health care costs and biologic therapy use in Turkey pp. 1-7

Onur Baser, Erdem Baser, Akif Altinbas and Abdulkadir Burkan

Cost analysis of glatiramer acetate vs. fingolimod for the treatment of patients with relapsing-remitting multiple sclerosis in Spain pp. 1-5

Rainel Sanchez- de la Rosa, Eliazar Sabater and Miguel Casado

The high cost of celiac disease in an Israeli Health Maintenance Organization pp. 1-5

Anthony Heymann, Moshe Leshno, Ronit Endevelt and Raanan Shamir

US Farm households: joint decision making and impact of health insurance on labor market outcomes pp. 1-19

Latika Bharadwaj, Jill Findeis and Sachin Chintawar

A cost-effectiveness analysis of respiratory syncytial virus (RSV) prophylaxis in infants in the United Kingdom pp. 1-12

Anthony Bentley, Ivana Filipovic, Katherine Gooch and Katharina Büsch

National health insurance, social influence and antenatal care use in Ghana pp. 1-12

Nkechi Owoo and Monica Lambon-Quayefio

Cost of illness studies on reproductive, maternal, newborn, and child health: a systematic literature review pp. 1-12

Sanjib Saha and Ulf-G. Gerdtham

Treatment of type 2 diabetes with saxagliptin: a pharmacoeconomic evaluation in Argentina pp. 1-9

Jorge Elgart, Joaquin Caporale, Lorena Gonzalez, Eleonora Aiello, Maximiliano Waschbusch and Juan Gagliardino

The impact of weight loss among seniors on Medicare spending pp. 1-6

Kenneth Thorpe, Zhou Yang, Kathleen Long and W Garvey

Is quality costly? Patient and hospital cost drivers in vascular surgery pp. 1-13

Marie Kruse and Jan Christensen

Patients’ mobility as an indicator for (in)efficiency:a panel data analysis on Italian health care authorities pp. 1-13

Elisabetta Mafrolla and Eugenio D’Amico

Impact of radiofrequency ablation for patients with varicose veins on the budget of the German statutory health insurance system pp. 1-17

Alexander Kuhlmann, Anne Prenzler, Jan Hacker and Johann Graf von der Schulenburg

Social costs of icatibant self-administration vs. health professional-administration in the treatment of hereditary angioedema in Spain pp. 1-11

Antonio Blasco, Pablo Lázaro, Teresa Caballero and Mar Guilarte

Simulation model for cost estimation of integrated care concepts of heart failure patients pp. 1-11

Joerg Schroettner and Alexander Lassnig

Will vaccination against rotavirus infection with RIX4414 be cost-saving in Germany? pp. 1-11

Stefanie Knoll, Christoph Mair, Ursula Benter, Katja Vouk and Baudouin Standaert

Evaluating the concordance of physician judgments and patient preferences on AIDS/HIV therapy - a Discrete Choice Experiment pp. 1-11

Axel Mühlbacher, Matthias Stoll, Jörg Mahlich and Matthias Nübling

Impact of specialization in gynecology and obstetrics departments on pregnant women’s choice of maternity institutions pp. 1-11

Yoshimi Adachi, Hiroyasu Iso, Junyi Shen, Kanami Ban, On Fukui, Hiroyuki Hashimoto, Takako Nakashima, Kenichiro Morishige and Tatsuyoshi Saijo

Confounding and missing data in cost-effectiveness analysis: comparing different methods pp. 1-11

Tommi Härkänen, Timo Maljanen, Olavi Lindfors, Esa Virtala and Paul Knekt

Short term cost effectiveness of a regional myocardial infarction network pp. 1-8

Ralf Birkemeyer, Anke Dauch, Alfred Müller, Manfred Beck, Henrik Schneider, Hueseyin Ince, Werner Jung and Steffen Wahler

Volume 2, issue 1, 2012

Community-based health insurance and social capital: a review pp. 1-5

Hermann Donfouet and Pierre-Alexandre Mahieu

Economic burden of osteoporotic fractures in Austria pp. 1-10

Hans Dimai, Kurt Redlich, Monika Peretz, Fredrik Borgström, Uwe Siebert and Jörg Mahlich

A cost-benefit analysis on the specialization in departments of obstetrics and gynecology in Japan pp. 1-10

Junyi Shen, On Fukui, Hiroyuki Hashimoto, Takako Nakashima, Tadashi Kimura, Kenichiro Morishige and Tatsuyoshi Saijo

A modified Kakwani measure for health inequality pp. 1-7

Mototsugu Fukushige, Noriko Ishikawa and Satoko Maekawa

The national health insurance scheme: perceptions and experiences of health care providers and clients in two districts of Ghana pp. 1-13

Philip Dalinjong and Alexander Laar

Potential cost-effectiveness and benefit-cost ratios of adult pneumococcal vaccination in Germany pp. 1-13

Alexander Kuhlmann, Ulrike Theidel, Mathias Pletz and Johann Graf von der Schulenburg

Estimating cost-effectiveness in public health: a summary of modelling and valuation methods pp. 1-6

Kevin Marsh, Ceri Phillips, Richard Fordham, Evelina Bertranou and Janine Hale

Wealth and antenatal care use: implications for maternal health care utilisation in Ghana pp. 1-8

Eric Arthur

Biologic TNF inhibiting agents for treatment of inflammatory rheumatic diseases: dosing patterns and related costs in Switzerland from a payers perspective pp. 1-8

Jan Zeidler, Thomas Mittendorf, Rüdiger Müller and Johannes von Kempis

The effects of public and private health care expenditure on health status in sub-Saharan Africa: new evidence from panel data analysis pp. 1-8

Jacob Novignon, Solomon Olakojo and Justice Nonvignon

The costs of schizophrenia and predictors of hospitalisation from the statutory health insurance perspective pp. 1-8

Jan Zeidler, Lara Slawik, Jochen Fleischmann and Wolfgang Greiner

Cost analysis of HIV treatment and drug-related adverse events when fixed-dose combinations of antiretrovirals (FDCs) were stopped, versus continuation with FDCs pp. 1-9

Francesc Homar, Virginia Lozano, Juan Martínez-Gómez, Itziar Oyagüez, Antonio Pareja, Antoni Payeras, Joaquín Serrano, Carmen Carratalá and Miguel Casado

Budgetary impact analysis of buprenorphine-naloxone combination (Suboxone ® ) in Spain pp. 1-9

Jose Martinez-Raga, Francisco Gonzalez-Saiz, Julian Oñate, Itziar Oyagüez, Eliazar Sabater and Miguel Casado

Assessing DRG cost accounting with respect to resource allocation and tariff calculation: the case of Germany pp. 1-12

Matthias Vogl

Methodological considerations in cost of illness studies on Alzheimer disease pp. 1-12

Nagede Costa, Helene Derumeaux, Thomas Rapp, Valérie Garnault, Laura Ferlicoq, Sophie Gillette, Sandrine Andrieu, Bruno Vellas, Michel Lamure, Alain Grand and Laurent Molinier

Cost-effectiveness analysis of antipsychotics in reducing schizophrenia relapses pp. 1-12

Antonio García-Ruiz, Lucía Pérez-Costillas, Ana Montesinos, Javier Alcalde, Itziar Oyagüez and Miguel Casado

Which patients do I treat? An experimental study with economists and physicians pp. 1-11

Marlies Ahlert, Stefan Felder and Bodo Vogt

Volume 1, issue 1, 2011

Quality of life results of balloon kyphoplasty versus non surgical management for osteoporotic vertebral fractures in Germany pp. 1-7

Daniela Eidt-Koch and Wolfgang Greiner

Flat-of-the-curve medicine: a new perspective on the production of health pp. 1-10

Johannes Schoder and Peter Zweifel

Measuring economic consequences of preterm birth - Methodological recommendations for the evaluation of personal burden on children and their caregivers pp. 1-10

Jan-Marc Hodek, Johann Graf von der Schulenburg and Thomas Mittendorf

Greetings from the Editors pp. 1-2

Johann Graf von der Schulenburg and Sebastian Braun

Socio-economic inequality of immunization coverage in India pp. 1-6

Jørgen Lauridsen and Jalandhar Pradhan

Promoting vaccinations - an analysis of measures taken by German statutory health insurers pp. 1-6

Kathrin Damm, Jana Schubert and Johann Graf von der Schulenburg

The effect of seniority and education on departmental dictation utilization pp. 1-6

Kevin Bax, Kambiz Norozi, Ajay Sharma and Guido Filler

Costing of physical activity programmes in primary prevention: a review of the literature pp. 1-15

Silke Wolfenstetter and Christina Wenig

Mind the information gap: fertility rate and use of cesarean delivery and tocolytic hospitalizations in Taiwan pp. 1-15

Ke-Zong Ma, Edward Norton and Shoou-Yih Lee

Efficiency of primary care in rural Burkina Faso. A two-stage DEA analysis pp. 1-15

Paul Marschall and Steffen Flessa

Transitivity in health utility measurement: An experimental analysis pp. 1-4

Ulrich Schmidt and Michael Stolpe

Balance billing: the patients' perspective pp. 1-14

Mathias Kifmann and Florian Scheuer

The effect of job stress on smoking and alcohol consumption pp. 1-14

Sunday Azagba and Mesbah Sharaf

Considerations about the effectiveness and cost effectiveness of therapies in the treatment of hyperphosphataemia pp. 1-9

Thomas Plagemann, Anne Prenzler and Thomas Mittendorf

Private hospital accreditation and inducement of care under the ghanaian national insurance scheme pp. 1-9

Eugenia Amporfu

Cycling and walking for transport: Estimating net health effects from comparison of different transport mode users' self-reported physical activity pp. 1-9

Knut Veisten, Stefan Flügel, Farideh Ramjerdi and Harald Minken

Staff costs of hospital-based outpatient care of patients with cystic fibrosis pp. 1-8

Helge Hollmeyer, Jonas Schreyögg, Ulrich Wahn and Doris Staab

The effects of drug market regulation on pharmaceutical prices in Europe: overview and evidence from the market of ACE inhibitors pp. 1-8

Fritz von der Schulenburg, Sotiris Vandoros and Panos Kanavos

Healthy vs. unhealthy food: a strategic choice for firms and consumers pp. 1-8

Fernando Antoñanzas and Roberto Rodríguez-Ibeas